REXIMMUNE-C Trademark

Trademark Overview

On Saturday, September 3, 2005, a trademark application was filed for REXIMMUNE-C with the United States Patent and Trademark Office. The USPTO has given the REXIMMUNE-C trademark a serial number of 78706667. The federal status of this trademark filing is REGISTERED AND RENEWED as of Monday, February 13, 2017. This trademark is owned by Epeius Biotechnologies Corporation. The REXIMMUNE-C trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, lesion-targeted vectory carrying immune response genes for use in the treatment of cancer, inflammatory and immunologic disorders
reximmune-c

General Information

Serial Number78706667
Word MarkREXIMMUNE-C
Filing DateSaturday, September 3, 2005
Status800 - REGISTERED AND RENEWED
Status DateMonday, February 13, 2017
Registration Number3269885
Registration DateTuesday, July 24, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 25, 2006

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, lesion-targeted vectory carrying immune response genes for use in the treatment of cancer, inflammatory and immunologic disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 12, 2005
Primary Code005
First Use Anywhere DateTuesday, November 22, 2005
First Use In Commerce DateTuesday, November 22, 2005

Trademark Owner History

Party NameGENVIVO, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSAN MARINO, CA 91108
Party NameEpeius Biotechnologies Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Marino, CA 91108
Party NameEpeius Biotechnologies Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Marino, CA 91108
Party NameEpeius Biotechnologies Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMonrovia, CA 92016

Trademark Events

Event DateEvent Description
Wednesday, January 30, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, February 13, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Monday, February 13, 2017REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, February 13, 2017REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, February 8, 2017TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Monday, December 5, 2016POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Monday, December 5, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, September 23, 2016TEAS SECTION 8 & 9 RECEIVED
Sunday, July 24, 2016COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, December 19, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, December 19, 2013REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, December 10, 2013REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Thursday, December 19, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, December 10, 2013TEAS SECTION 8 & 15 RECEIVED
Thursday, November 20, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 20, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 20, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 24, 2007REGISTERED-PRINCIPAL REGISTER
Thursday, June 21, 2007LAW OFFICE REGISTRATION REVIEW COMPLETED
Thursday, June 21, 2007ASSIGNED TO LIE
Wednesday, May 23, 2007ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, May 22, 2007STATEMENT OF USE PROCESSING COMPLETE
Friday, February 16, 2007USE AMENDMENT FILED
Friday, February 16, 2007TEAS STATEMENT OF USE RECEIVED
Tuesday, October 17, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 25, 2006PUBLISHED FOR OPPOSITION
Wednesday, July 5, 2006NOTICE OF PUBLICATION
Wednesday, June 7, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, May 22, 2006ASSIGNED TO LIE
Wednesday, April 12, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 24, 2006ASSIGNED TO LIE
Friday, March 17, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 17, 2006ASSIGNED TO EXAMINER
Monday, September 12, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

reximmune treatment genes cancer inflammatory disorders immunologic response immune namely preparations